Retrospective claims study reveals significant corticosteroid sparing alongside frequent treatment switches in myasthenia gravis, highlighting the need for personalized management approaches.
No takes yet. Share an insight, caveat, or question.
Tard et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: